InsiderClue
← All stocks

EXAGEN INC.

XGN Net selling
CIK 0001274737 #3988 in the set updated 17 Sep 2026
Bought (120 mo)
$6.42M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$11.27M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$11.27M
60 of 60 sales
Net
−$4.86M
−$4.86M against sales at will

By person

13 insiders · 77 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
H.I.G. Bio-Exagen, L.P.
10% owner
$5.95M (1)
—
+$5.95M
1,696,252
7.00%
$12.24M
—
NMSIC Co-Investment Fund, L.P. entity
10% owner
—
$4.90M (4)
−$4.90M
4,067,916
16.79%
$29.36M
+75.3%
Hunt Holdings Limited Partnership entity
10% owner
—
$3.61M (12)
−$3.61M
1,261,324
5.21%
$9.10M
+176,063%
TULLIS JAMES L L
10% owner
$519.45 (1)
$1.80M (30)
−$1.80M
4,614,499
19.05%
$33.31M
+50.2%
Black Jeffrey G.
Chief Financial Officer
$66.45K (1)
$354.86K (3)
−$288.41K
324,910
1.34%
$2.35M
+1,095%
ABALLI JOHN
President and CEO
$387.07K (3)
$532.70K (4)
−$145.64K
880,235
3.63%
$6.35M
—
Adawi Kamal
CFO and Corporate Secretary
—
$61.64K (5)
−$61.64K
243,749
1.01%
$1.76M
—
Hazeltine Mark
Chief Business Officer
—
$15.67K (2)
−$15.67K
190,205
0.7851%
$1.37M
+407.2%
Johnson Wendy S.
Director
$14.02K (1)
—
+$14.02K
1,000
0.0041%
$7.22K
—
TULLIS DICKERSON CAPITAL FOCUS III, L.P. entity
10% owner
—
—
—
1,625,165
6.71%
$11.73M
+1,641,481%
Rocca Fortunato R.
President and CEO
—
—
—
120,678
0.4981%
$870.99K
—
Zack Debra
Chief Medical Officer
—
—
—
84,259
0.3478%
$608.14K
—
PALLARES EBETUEL
Director
—
—
—
1,185
0.0049%
$8.55K
+562.0%

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
Black Jeffrey G.
15 Nov 2024
Chief Financial Officer
Buy
22,298
$2.98
$66.45K
ABALLI JOHN
14 Nov 2024
President and CEO
Buy
24,305
$2.81
$68.30K
ABALLI JOHN
16 May 2024
President and CEO
Buy indirect
40,401
$1.92
$77.57K
TULLIS JAMES L L
15 Jun 2023
10% owner
Buy indirect
167
$3.11
$519.45
ABALLI JOHN
8 Dec 2022
President and CEO
Buy
90,000
$2.68
$241.20K
Johnson Wendy S.
3 Sep 2021
Director
Buy
1,000
$14.02
$14.02K
H.I.G. Bio-Exagen, L.P.
23 Sep 2019
10% owner
Buy indirect
425,000
$14.00
$5.95M
Show all 77 transactions →

What was left out

Form 4 filings counted 133
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 60
Transactions with no price 0
Shares from compensation/vesting 11,557,817
Sales filed before the plan box existed 48
History held since 20 Sep 2019